North America Thyroid Eye Disease Market Size & Outlook, 2026-2034


North America Thyroid Eye Disease Market Insights

  • Based on Reed Intelligence findings, the North America Thyroid Eye Disease Market size reached USD 411.1 Million in 2025 and is expected to grow to USD 747.37 Million by 2034.
  • During 2026–2034, the market is forecasted to advance at a CAGR of 6.89%.
  • Biologics represented the largest share of the Therapy Type market in terms of size in 2025.
  • Among the Therapy Type segments, Corticosteroids is forecasted to achieve the highest growth and remain the most lucrative through the forecast period.

Other Key Findings


  • In 2025, North America contributed 34.84% to the overall global Thyroid Eye Disease Market size.
  • By 2034, United States is anticipated to dominate the global market based on market size.
  • Canada is expected to witness the fastest growth within North America, attaining USD 180.03 Million by 2034.

Report Summary

Report Scope Details
Base Year for Study 2025
Study Period 2022-2034
Historical Period 2022-2024
Forecast Period 2026-2034
Market Size In 2025 USD 411.1 Million
Market Size In 2034 USD 747.37 Million
Largest segment Biologics
Units Revenue in USD Million
CAGR 6.89% (2026-2034)
Segmnetation Covered
North America
  1. United States
  2. Canada
Therapy Type
  1. Biologics
  2. Small Molecule Drugs
  3. Corticosteroids
Treatment Approach
  1. Pharmacological Therapy
  2. Combination Therapy
  3. Surgical Intervention
Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Related Reports